Treatment of cutaneous leishmaniasis with antimony: Intramuscular versus intralesional administration

Annals of Tropical Medicine and Parasitology

Volumn 91, Issue 8, 1997, Pages 899-905

  Alkhawajah, A M ^a   Larbi, E ^a   Al Gindan, Y ^a   Abahussein, A ^a   Jain, S ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY; MEGLUMINE ANTIMONATE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HEALING; HEART DISEASE; HUMAN; INTRALESIONAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; KIDNEY DISEASE; LIVER DISEASE; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; SKIN LEISHMANIASIS; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

PROTOZOA;

EID: 0031473983     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1080/00034983.1997.11813217     Document Type: Article

References (25)

1. ALKHAWAJAH, A. M., JAIN, S., LARBI, E. M., AL-GINDAN, Y. & ABAHUSSIEN, A. (1995). The efficacy of different dosage regimens of pentavalent antimony compounds on cutaneous leishmaniasis in mice. Saudi Pharmaceutical Journal, 3, 36-40.
2. BARRIOS, L. A., COSTA, J. M. L., NETTO, E. M., VEXENAT, E. O. R., CUBBA, C. C. & MARSDEN, P. D. (1986). Intralesional glucantime in Leishmania braziliensis braziliensis infections. Transactions of the Royal Society of Tropical Medicine and Hygiene, 80, 173-174.
3. BARSKY, S., STORINO, W., SALGEA, K. & KNAPP, P. (1978). Cutaneous leishmaniasis: surgical management of a case with unusual clinical and histological features. Archives of Dermatology, 114, 1354-1355.
4. BASSIOUNY, A., ELMESHAD, M., TALAAT, M., KUTTY, K. & METAWAA, B. (1982). Cryotherapy in cutaneous leishmaniasis. British Journal of Dermatology, 107, 367-474.
5. BRYCESON, A. D. M., CHULY, J. D., MUGAMBI, M., WERE, J. B., GACHIBI, G., CHUNGE, C. N., MUIGAI, R., BHATT, S. M., HO, M., SPENCER, H. C., MEME, J. & ANABWANI, G. (1985). Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dose of sodium stibogluconate or prolonged treatment with pentamidine. Transactions of the Royal Society of Tropical Medicine and Hygiene, 79, 705-714.
6. CHANCE, M. L. (1995). New developments in the chemotherapy of leishmaniasis. Annals of Tropical Medicine and Parasitology, 89 (Suppl.1), 37-43.
7. EL-SAFI, S. H., MURPHY, A. G., BRYCESON, A. D. M. & NEAL, R. A. (1990). A double blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 690-691.
8. FERRY, A. P. (1977). Cutaneous leishmaniasis (oriental sore) of the eyelid. American Journal of Ophthalmology, 48, 349.
9. GRIFFITHS, W. A. D. & CROFT, S. L. (1980). Cutaneous leishmaniasis. Postgraduate Doctor, Middle East Edition, 3, 388-394.
10. HARMAN, R. R. M. (1979). Parasitic worms and protozoa. In Textbook of Dermatology, Vol. 1, 3rd Edn, eds Rook, A., Wilkinson, D. S. & Ebling, F. J. G. pp. 903-904. Oxford: Blackwell Scientific.
11. HENRIKSEN, T. H. & LEND, E. S. (1983). Treatment of diffused cutaneous leishmaniasis with chlorpromazine ointment. Lancet, i, 126.
12. KELLUM, R. E. (1986). Treatment of cutaneous leishmaniasis with an intralesional antimonial drug (pentostam). Journal of the American Academy of Dermatology, 15, 620-622.
13. LARBI, E. M., ALKHAWAJAH, A. M., AL-GIDAN, Y., JAIN, S., ABAHUSAIN, A. & AL-ZAYER, A. (1995). A randomized, double-blind, clinical trial of topical clotrimazole versus miconazole for treatment of cutaneous leishmaniasis in the Eastern province of Saudi Arabia. American Journal of Tropical Medicine and Hygiene, 52, 166-168.
14. LOCKMAN, Y., VARDY, D., OHAYON, D. & EL-ON, J. (1991). The failure of traditionally used desert plants to act against cutaneous leishmaniasis in experimental animals. Annals of Tropical Medicine and Parasitology, 85, 499-501.
15. MARSDEN, P. D., SAMPAIO, R. N. R., CARVALHO, E. M, VEIGA, J. P. T., COSTA, J. L. M. & LLANOS-CUENTAS, E. A. (1985). High continuous antimony therapy in two patients with unresponsive mucocutaneous leishmaniasis. American Journal of Tropical Medicine and Hygiene, 34, 710-713.
16. NAVIN, T. R., ARANA, B. A., ARANA, F. E., BERMAN, J. D. & CHAJON, J. F. (1992). Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. Journal of Infectious Diseases, 165, 528-534.
17. NEVA, F. A., PETERSON, E. A., CORSAY, R., BOGAERRT, H. & MARTINEZ, D. (1984). Observations on local heat treatment of cutaneous leishmaniasis. American Journal of Tropical Medicine and Hygiene, 33, 800-804.
18. PAREEK, S. S. (1984). Combination of sodium stibogluconate and rifampicin in cutaneous leishmaniasis. International Journal of Dermatology, 23, 70-71.
19. PEARSON, J. K. & SAWICK, S. (1975). Metronidazole therapy for cutaneous leishmaniasis. Archives of Dermatology, 111, 1343-1344.
20. PETERS, W. & AL-ZAURANI, M. A. (1987). The leishmaniases-a public health problem in Saudi Arabia. Saudi Medical Journal, 8, 333-343.
21. RAU, R. C., DUBIN, H. V. & TAYLOR, W. B. (1976). Leishmania tropica infections in travelers. Archives of Dermatology, 12, 197-210.
22. SAGHER, F. (1975). Cutaneous leishmaniasis. In Clinical Tropical Dermatology, ed. Canizares, O. pp. 186-191. Oxford: Blackwell Scientific.
23. SEBAI, Z. A., MORSY, T. A. & SUROOR, F. J. (1975). Treatment of cutaneous leishmaniasis with sodium stibogluconate (pentostam) in Saudi Arabia. Journal of the Egyptian Public Health Association, 50, 59-62.
24. SHARQUIE, K. E., AL-TALIB, K. K. A. & CHU, A. C. (1988). Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony. British Journal of Dermatology, 119, 53-57.
25. WILCOCKS, C. & MANSON-BAHR, P. E. C. (Eds) (1978). Manson's Tropical Diseases, 17th Edn. Baltimore: Williams & Wilkins.